The current PE ratio of IONS can't be determined, as the TTM EPS of -$2.56 is negative. The last recorded PE ratio for Ionis Pharmaceuticals was 631.86 in September 2022.
The average historical PE ratio of Ionis Pharmaceuticals for the last nine years is 169.09. Over the past nine years, IONS's PE ratio was at its highest in the Sep 2022 quarter at 631.86, when the stock price was $44.23 and the EPS was $0.07. The lowest value was in the Sep 2019 quarter, when it reached 18.55 with a price of $59.91 and an EPS of $3.23.
Maximum annual increase: 16.78% in 2019
Maximum annual decrease: -92.29% in 2018
| Year | PE ratio | Change |
|---|---|---|
| 2023 | N/A | N/A |
| 2022 | N/A | N/A |
| 2021 | N/A | N/A |
| 2020 | N/A | N/A |
| 2019 | 30.21 | 16.78% |
| 2018 | 25.87 | -92.29% |
| 2017 | 335.33 | N/A |
| 2016 | N/A | N/A |
| 2015 | N/A | N/A |
| 2014 | N/A | N/A |
| Stock name | PE ratio | Market cap |
|---|---|---|
| NWBO Northwest Biotherapeutics Inc | N/A | $571.19M |
| IONS Ionis Pharmaceuticals Inc | N/A | $6.06B |
The current price to earnings ratio of IONS can't be calculated, as its EPS of -$2.56 is negative.
The 5-year average PE ratio for IONS stock is 127.96.
In the last nine years, the Sep 2022 quarter recorded the highest quarterly PE ratio at 631.86.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.